Evidence map›Paper›PMID 32541690›Full record

ArticleBone marrow transplantation2020

Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi.

Michele Merli, Stefano Luminari, Lucia Farina, Federica Cocito, Irene Defrancesco, Guido Gini, Annalisa Arcari, Greta Scapinello, Massimo Gentile, Maria Goldaniga and 15 more

Open access · greenAbstract readLetterMulticenter Study
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 15 institutions in 1 country.

Michele MerliHematology, University Hospital Ospedale di Circolo e Fondazione Macchi-ASST Sette Laghi, University of Insubria, Varese, Italy. michele.merli@asst-settelaghi.it.ORCID http://orcid.org/0000-0002-0905-5927
Stefano LuminariHematology Unit, Azienda USL IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Lucia FarinaHematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Federica CocitoDepartment of Hematology, S. Gerardo University Hospital, Monza, Italy.
Irene DefrancescoDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
Guido GiniDepartment of Hematology, Ospedali Riuniti, Ancona, Italy.
Annalisa ArcariHematology Unit, Ospedale Guglielmo da Saliceto, Piacenza, Italy.
Greta ScapinelloHematology Unit, Department of Medicine-DIMED, University of Padova, Padova, Italy.
Massimo GentileOnco-hematology, Hematology Unit, Azienda Ospedaliera of Cosenza, Cosenza, Italy.
Maria GoldanigaHematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Giacomo LosetoHematology, IRCCS Ospedale Oncologico Giovanni Paolo II, Bari, Italy.
Emanuele CenciniHematology, Azienda Ospedaliera Senese, University of Siena, Siena, Italy.ORCID http://orcid.org/0000-0002-0432-9706
Antonino GrecoDivision of Hematology, Ospedale G. Panico, Tricase, Lecce, Italy.
Anna Lia MolinariHematology, Ospedale degli Infermi, Rimini, Italy.
Andrea FerrarioHematology, University Hospital Ospedale di Circolo e Fondazione Macchi-ASST Sette Laghi, University of Insubria, Varese, Italy.
Benedetta BianchiHematology, University Hospital Ospedale di Circolo e Fondazione Macchi-ASST Sette Laghi, University of Insubria, Varese, Italy.
Barbara MoraHematology, University Hospital Ospedale di Circolo e Fondazione Macchi-ASST Sette Laghi, University of Insubria, Varese, Italy.
Lorenza BertùHematology, University Hospital Ospedale di Circolo e Fondazione Macchi-ASST Sette Laghi, University of Insubria, Varese, Italy.
Vincenzo SaturniApheresis Unit of Immunohematology and Transfusional Service, University Hospital Ospedale di Circolo e Fondazione Macchi-ASST Sette Laghi, Varese, Italy.
Fabio BergaminiDivision of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Nicole FabbriDivision of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Francesca Gaia RossiHematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Silvia BolisDepartment of Hematology, S. Gerardo University Hospital, Monza, Italy.
Francesco PassamontiHematology, University Hospital Ospedale di Circolo e Fondazione Macchi-ASST Sette Laghi, University of Insubria, Varese, Italy.
Luca ArcainiDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
University of Insubria · ITAzienda Ospedaliera San Gerardo · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITPoliclinico San Matteo Fondazione · ITUniversity of Pavia · ITAzienda Ospedaliera di Cosenza · ITAzienda Ospedaliero Universitaria Ospedali Riuniti · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITGuglielmo da Saliceto Hospital · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITOspedale degli Infermi · ITOspedale di Circolo e Fondazione Macchi · ITUniversity of Modena and Reggio Emilia · ITUniversity of Padua · ITUniversity of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lymphoma, Non-HodgkinNitrogen Mustard CompoundsAntineoplastic Combined Chemotherapy ProtocolsBendamustine HydrochlorideHematopoietic Stem Cell MobilizationHumansRituximabBendamustine HydrochlorideNitrogen Mustard CompoundsRituximab

Identifiers

PMID32541690
OpenAlexW3034945535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.